SCHEMBL52102

SCHEMBL52102

CC(=O)OC1C(=O)OC(=O)C1OC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.42
PRKCA P17252 4/20 0.33
PRKD3 O94806 3/20 0.33
PRKCG P05129 3/20 0.33
PRKCB P05771 3/20 0.33
PRKCH P24723 3/20 0.33
PRKCE Q02156 3/20 0.33
PRKCQ Q04759 3/20 0.33
PRKCD Q05655 3/20 0.33
PRKD1 Q15139 3/20 0.33
TSHR P16473 2/20 0.32
ALOX5 P09917 1/20 0.32
ALDH1A1 P00352 2/20 0.30
ABCB1 P08183 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8220668 1.00 POLB (0.42) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL7893349 1.00 POLB (0.42) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL2480467 1.00 POLB (0.42) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL1333553 1.00 POLB (0.42) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL12546111 0.87 POLB (0.37) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL18219141 0.87 POLB (0.37) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL15457672 0.87 POLB (0.37) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL10777104 0.80 POLB (0.40) POLBPRKCAPRKD3PRKCGPRKCB
SCHEMBL20799266 0.79 PRKCA (0.41) PRKCAPRKD3PRKCGPRKCBPRKCH
Aceglatone SCHEMBL8852 0.76 POLB (0.39) POLBPRKCAPRKD3PRKCGPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619580-A1 PRODUCTION OF HYDROPHOBIC PAPER SCA Forest Products AB (SE) 2025-09-24 EP claimed
US-20250161213-A1 OIL-IN-WATER EMULSION WITH AGAR AND DIACETYL TARTARIC ACID ESTERS OF MONO-AND DI-GLYCERIDES (DATEM) VITUX GROUP AS (NO) 2025-05-22 US claimed
CN-119569588-A Preparation method and intermediate of ilast hydrochloride 杭州诺澳生物医药科技有限公司 2025-03-07 CN claimed
CN-119486715-A Oil-in-water emulsion of diacetyl tartaric acid esters (DATEM) containing agar, mono-and diglycerides 维特斯集团 2025-02-18 CN claimed
EP-4486306-A1 OIL-IN-WATER EMULSION WITH AGAR AND DIACETYL TARTARIC ACID ESTERS OF MONO-AND DI-GLYCERIDES (DATEM) Vitux Group AS (NO) 2025-01-08 EP claimed
CN-118955285-A Preparation method of diacetyl tartaric acid mono-diglyceride 广州美晨科技实业有限公司 2024-11-15 CN claimed
CN-113348163-B Methods and compounds 雷迪厄斯制药公司 2024-10-08 CN claimed
WO-2024105160-A1 PRODUCTION OF HYDROPHOBIC PAPER SCA FOREST PRODUCTS AB (SE) 2024-05-23 WO claimed
CN-115385791-B Preparation method of diacetyl tartaric acid mono-diglyceride 常茂生物化学工程股份有限公司 2024-04-23 CN claimed
US-20240094216-A1 ODD CHAIN FATTY ACID THERAPY FOR THE TREATMENT OF MITOCHONDRIAL DISEASES UNIVERSITY OF SOUTH CAROLINA 2024-03-21 US claimed
US-6764541-B1 Colorant compositions XEROX CORPORATION 2004-07-20 US claimed
US-20040039137-A1 Graft polymers formed by using polyesterimides having cyclic dicarboxylic anhydride end groups; blends used to form carpet filaments or fibers THUERINGISCHES INSTITUT FUER TEXTIL-UND KUNSTSTOFF-FORSCHUNG E.V. (DE) 2004-02-26 US claimed
US-6583248-B1 Methacrylate groups; dental cement AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION 2003-06-24 US claimed
EP-1309253-A1 METHODS, AGENTS AND DEVICES FOR REMOVING NUCLEOPHILIC TOXINS FROM TOBACCO AND TOBACCO SMOKE Cerami Consulting Corporation (US) 2003-05-14 EP claimed
WO-2002000046-A1 METHODS, AGENTS AND DEVICES FOR REMOVING NUCLEOPHILIC TOXINS FROM TOBACCO AND TOBACCO SMOKE CERAMI CONSULTING CORP. (US) 2002-01-03 WO claimed
US-6180739-B1 CYCLODEXTRINS WITH ACRYLATE AND ANHYDRIDES AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION 2001-01-30 US claimed
US-6119701-A USING A FILTER ELEMENT COMPRISING A POLYMER DERIVATIZED WITH ALDEHYDIC GROUPS, E.G., CELLULOSE DIALDEHYDE, DIALDEHYDE STARCHES; DETOXIFICATION WITHOUT REMOVAL OF THE NICOTINE AND FLAVOR; CIGARETTES, CIGARS, PIPES AND ROOM AIR FILTERS CERAMI CONSULTING CORP. (US) 2000-09-19 US claimed
US-6113678-A Hot melt inks containing polyanhydrides XEROX CORPORATION (US) 2000-09-05 US claimed
US-5929131-A Polymerizable cyclodextrin derivatives AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1999-07-27 US claimed
US-5792821-A Polymerizable cyclodextrin derivatives AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1998-08-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240094216-A1 ODD CHAIN FATTY ACID THERAPY FOR THE TREATMENT OF MITOCHONDRIAL DISEASES NDUFAB1, OAT, CPT2 POLB 673/4885PRKCA 2663/4885PRKD3 3557/4885
US-20250161213-A1 OIL-IN-WATER EMULSION WITH AGAR AND DIACETYL TARTARIC ACID ESTERS OF MONO-AND DI-GLYCERIDES (DATEM) DAGLA, DAGLB, MGLL POLB 592/4885PRKCA 2475/4885PRKD3 3148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.